Sinco Pharmaceuticals Holdings Limited

SEHK:6833 Rapporto sulle azioni

Cap. di mercato: HK$382.2m

Sinco Pharmaceuticals Holdings Gestione

Gestione criteri di controllo 3/4

Sinco Pharmaceuticals Holdings Il CEO è Min Jin, nominato in Mar2023, e ha un mandato di 1.67 anni. la retribuzione annua totale è CN¥ 1.96M, composta da 94.6% di stipendio e 5.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.67% delle azioni della società, per un valore di HK$ 2.57M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1.8 anni e 6 anni.

Informazioni chiave

Min Jin

Amministratore delegato

CN¥2.0m

Compenso totale

Percentuale dello stipendio del CEO94.6%
Mandato del CEO1.7yrs
Proprietà del CEO0.7%
Durata media del management1.8yrs
Durata media del Consiglio di amministrazione6yrs

Aggiornamenti recenti sulla gestione

Recent updates

What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Oct 04
What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You

Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Aug 16
Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Apr 02
Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings

Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Mar 08
Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Nov 07
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Jun 26
A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)

Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

May 30
Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?

Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Oct 26
Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

Feb 04
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today

I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Oct 25
I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease

Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Jun 10
Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings

Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

May 24
Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt

Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

Apr 20
Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock

We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

Feb 16
We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings

How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 11
How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?

Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Dec 07
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Min Jin rispetto agli utili di Sinco Pharmaceuticals Holdings?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

CN¥47m

Mar 31 2024n/an/a

CN¥44m

Dec 31 2023CN¥2mCN¥2m

CN¥42m

Sep 30 2023n/an/a

CN¥35m

Jun 30 2023n/an/a

CN¥27m

Mar 31 2023n/an/a

CN¥48m

Dec 31 2022CN¥2mCN¥2m

CN¥69m

Compensazione vs Mercato: La retribuzione totale di Min ($USD 272.91K ) è circa la media per le aziende di dimensioni simili nel mercato Hong Kong ($USD 236.00K ).

Compensazione vs guadagni: La retribuzione di Min è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Min Jin (46 yo)

1.7yrs

Mandato

CN¥1,959,000

Compensazione

Mr. Min Jin is Chief Accountant since August 17, 2023 and Secretary since December 21, 2023 at Nanjing Tanker Corporation. He was Co-Chief Executive Officer at Sinco Pharmaceuticals Holdings Limited since...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Xiangbin Huang
Executive Chairman13.6yrsCN¥7.10m51.65%
HK$ 197.4m
Min Jin
Chief Executive Officer1.7yrsCN¥1.96m0.67%
HK$ 2.6m
Shifeng Lei
Executive Directorno dataCN¥1.09mNessun dato
Yifan Li
Chief Financial Officer9.4yrsNessun datoNessun dato
Zhijian Huang
Executive Directorless than a yearNessun datoNessun dato
Yunlu Peng
Company Secretary5.1yrsNessun datoNessun dato
Tao Zhang
President of Sichuan Sinco Pharmaceuticals Co. Ltd.2yrsNessun datoNessun dato

1.8yrs

Durata media

44yo

Età media

Gestione esperta: Il team dirigenziale di 6833 non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Xiangbin Huang
Executive Chairman13.6yrsCN¥7.10m51.65%
HK$ 197.4m
Shifeng Lei
Executive Director1.7yrsCN¥1.09mNessun dato
Zhijian Huang
Executive Directorless than a yearNessun datoNessun dato
Ying Kit Lau
Independent Non-Executive Director6yrsCN¥300.00kNessun dato
Wenfang Liu
Independent Non-Executive Director8.8yrsCN¥300.00kNessun dato
Qing Wang
Independent Non-Executive Director8.8yrsCN¥300.00kNessun dato
Zhizhong Bai
Independent Non-Executive Director4.2yrsCN¥300.00kNessun dato

6.0yrs

Durata media

58yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 6833 sono considerati esperti (durata media dell'incarico 6 anni).